ArticleJournal for immunotherapy of cancer2025

Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression.

Kaifeng Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.